Details

Published: 29 July 2021

• In March, Barbara was diagnosed with an aggressive malignant brain tumor, called a glioblastoma.
• She was the first patient to be treated in a focused ultrasound clinical trial at the University of Virginia.
• Read Barbara’s story and learn about her hopes for how focused ultrasound could affect her future and that of countless others.

Read more ...

Details

Published: 29 July 2021

• The meeting covered methods for confirming and quantifying drug/therapeutic delivery following blood-brain barrier opening (BBBO).
• Representatives from the Foundation and focused ultrasound experts from five leading institutions participated.
• A follow up consortium was created to further address the topic.

Read more ...

Details

Published: 29 July 2021

• The Foundation supports the modernization of our healthcare policies to drive innovative medical technologies and improve patient outcomes, as expressed in the recent 21st Century Cures 2.0 discussion draft.

Read more ...

Details

Published: 29 July 2021

• Sonodynamic therapy (SDT) uses focused ultrasound to activate compounds called sonosensitizers, which then produce a local cytotoxic effect.
• Researchers recently published a preclinical safety study and a review of the technology as used in gliomas.
• A first-in-human clinical trial using SDT to treat glioblastoma is now recruiting in Arizona.

Read more ...